The Top Five “Game Changers” in Vaccinology: Toward Rational and Directed Vaccine Development

scientific article published on 04 August 2011

The Top Five “Game Changers” in Vaccinology: Toward Rational and Directed Vaccine Development is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1089/OMI.2011.0012
P953full work available at URLhttp://www.liebertpub.com/doi/full-xml/10.1089/omi.2011.0012
http://www.liebertpub.com/doi/pdf/10.1089/omi.2011.0012
https://doi.org/10.1089/omi.2011.0012
https://europepmc.org/articles/PMC3166183
https://europepmc.org/articles/pmc3166183?pdf=render
https://europepmc.org/articles/PMC3166183?pdf=render
P932PMC publication ID3166183
P698PubMed publication ID21815811
P5875ResearchGate publication ID51546415

P50authorRichard B KennedyQ97591233
Gregory A. PolandQ22096751
P2860cites workJournal of Clinical InvestigationQ3186904
Identification of a universal Group B streptococcus vaccine by multiple genome screenQ34313096
Systems vaccinologyQ34402910
Stunned silence: gene expression programs in human cells infected with monkeypox or vaccinia virusQ34498815
Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus ankara is comparable to that of DryvaxQ36424513
Next-generation sequencing: applications beyond genomesQ36928719
Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomicsQ36986515
Loss-of-function variants in endothelial lipase are a cause of elevated HDL cholesterol in humansQ37143381
Bioinformatics approaches for genomics and post genomics applications of next-generation sequencingQ37623244
Personalized dendritic cell-based tumor immunotherapyQ37693733
Immunoinformatics and systems biology methods for personalized medicineQ37786271
Vaccines and the future of human immunologyQ37804529
Integrated analysis of ATM mediated gene and protein expression impacting cellular metabolism.Q39591869
Single nucleotide polymorphisms in genes for 2'-5'-oligoadenylate synthetase and RNase L inpatients hospitalized with West Nile virus infectionQ40495949
Infection of mouse neurones by West Nile virus is modulated by the interferon-inducible 2'-5' oligoadenylate synthetase 1b proteinQ40558923
ASSIMILATOR: a new tool to inform selection of associated genetic variants for functional studiesQ41433486
Vaccinomics, Predictive Vaccinology And The Future of Vaccine DevelopmentQ51772775
Pharmacology, vaccinomics, and the second golden age of vaccinologyQ53169887
Personalized vaccines: the emerging field of vaccinomicsQ57157844
Gene expression profiling of monkeypox virus-infected cells reveals novel interfaces for host-virus interactionsQ21245114
A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infectionQ24294658
Trends affecting the future of vaccine development and delivery: the role of demographics, regulatory science, the anti-vaccine movement, and vaccinomicsQ24648874
A nonsense mutation in the gene encoding 2'-5'-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory miceQ27471916
Genetic Variation in OAS1 Is a Risk Factor for Initial Infection with West Nile Virus in ManQ27487937
Sequencing technologies - the next generationQ27860568
Is systems biology the key to preventing the next pandemic?Q28473401
Computational solutions to large-scale data management and analysisQ28743172
Systems integration of biodefense omics data for analysis of pathogen-host interactions and identification of potential targetsQ28751538
Systems biology of innate immunityQ28752485
Systems biology approach predicts immunogenicity of the yellow fever vaccine in humansQ29616204
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosisQ29618105
Applications of next-generation sequencing technologies in functional genomicsQ29619225
Influenza A viruses: why focusing on M2e-based universal vaccinesQ30396318
InnateDB: facilitating systems-level analyses of the mammalian innate immune response.Q30484002
Proteomic basis of the antibody response to monkeypox virus infection examined in cynomolgus macaques and a comparison to human smallpox vaccination.Q30994031
SNPs in Multi-species Conserved Sequences (MCS) as useful markers in association studies: a practical approachQ33293455
Next-generation sequencing: a transformative tool for vaccinologyQ33744262
Systems biology of interstitial lung diseases: integration of mRNA and microRNA expression changesQ33795193
Vaccinomics and bioinformatics: accelerants for the next golden age of vaccinologyQ33814924
Integration of lipidomics and transcriptomics data towards a systems biology model of sphingolipid metabolismQ33814929
Variation in antiviral 2',5'-oligoadenylate synthetase (2'5'AS) enzyme activity is controlled by a single-nucleotide polymorphism at a splice-acceptor site in the OAS1 geneQ33942146
Simultaneous high-resolution analysis of vaccinia virus and host cell transcriptomes by deep RNA sequencingQ33953053
The art of the probable: system control in the adaptive immune systemQ34307986
P433issue9
P407language of work or nameEnglishQ1860
P304page(s)533-537
P577publication date2011-08-04
P13046publication type of scholarly workreview articleQ7318358
P1433published inOMICS A Journal of Integrative BiologyQ15753054
P1476titleThe top five "game changers" in vaccinology: toward rational and directed vaccine development
The Top Five “Game Changers” in Vaccinology: Toward Rational and Directed Vaccine Development
P478volume15

Reverse relations

cites work (P2860)
Q28074461Anaplasma marginale: Diversity, Virulence, and Vaccine Landscape through a Genomics Approach
Q37443100Comparison of the live attenuated yellow fever vaccine 17D-204 strain to its virulent parental strain Asibi by deep sequencing
Q42040401Coping with genetic diversity: the contribution of pathogen and human genomics to modern vaccinology
Q97519043Current Challenges in Vaccinology
Q55314046Emergence of Leptin in Infection and Immunity: Scope and Challenges in Vaccines Formulation.
Q26782451Enhancing vaccine safety capacity globally: A lifecycle perspective
Q38140041Exploitation of physiology and metabolomics to identify pneumococcal vaccine candidates
Q30951944High-throughput data analysis and data integration for vaccine trials
Q41901935Host defense pathways against fungi: the basis for vaccines and immunotherapy
Q36680938Leptin-based adjuvants: An innovative approach to improve vaccine response
Q30366743Molecular mechanisms for enhanced DNA vaccine immunogenicity.
Q41996442Successes and failures in human tuberculosis vaccine development.
Q38075096Systems approach to tuberculosis vaccine development
Q39759401The composition of immune cells serves as a predictor of adaptive immunity in a cohort of 50- to 74-year-old adults
Q36438236The future of human DNA vaccines
Q36603325The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approaches
Q38186857The link between genetic variation and variability in vaccine responses: systematic review and meta-analyses
Q51416013Vaccines Meet Big Data: State-of-the-Art and Future Prospects. From the Classical 3Is ("Isolate-Inactivate-Inject") Vaccinology 1.0 to Vaccinology 3.0, Vaccinomics, and Beyond: A Historical Overview.
Q21089599Vaccines: From Empirical Development to Rational Design
Q24261399Vaccinology in the third millennium: scientific and social challenges
Q48420180Vaccinology: The name, the concept, the adjectives
Q37119456Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century
Q36373260Variability in Humoral Immunity to Measles Vaccine: New Developments
Q36733384Variation between Populations in the Innate Immune Response to Vaccine Adjuvants

Search more.